(Q44438100)

3 December 2017

title

Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters (English)

1 reference

3 December 2017

I. Wiegratz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742558

1 January 2024

E. Kutschera

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742558

1 January 2024

J. H. Lee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742558

1 January 2024

C. Moore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742558

1 January 2024

U. Mellinger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742558

1 January 2024

U. H. Winkler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742558

1 January 2024

H. Kuhl

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742558

1 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12742558

1 January 2024

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://api.elsevier.com/content/article/PII:S0010782403000064?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0010-7824(03)00006-4

https://api.elsevier.com/content/article/PII:S0010782403000064?httpAccept=text/plain

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0010-7824(03)00006-4

1 January 2024

1 reference

3 December 2017

volume

67

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

361-366

1 reference

Serum tsh and serum t3 levels during normal menstrual cycles and during cycles on oral contraceptives

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroid-binding globulin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Plasma-aldosterone during oral-contraceptive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Metabolic effects of the triphasic oral contraceptive Trigynon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Thyroid function during treatment with a new oral contraceptive combination containing desogestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Effect of four different oral contraceptives on various sex hormones and serum-binding globulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

The Effect of Droloxifene and Estrogen on Thyroid Function in Postmenopausal Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Comparative effectes of ethinyl estradiol, 17alpha-ethyl-19-nortestosterone and methyltestosterone on the plasma clearance on infused cortisol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Effects of ethinylestradiol on the renin-angiotensin-aldosterone-system and on plasma transcortin in women and men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Effects of oral contraceptive therapy on the renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Metabolic changes in women using a long-acting monthly oral contraceptive and return of ovulation on discontinuation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Hypertension, oral contraceptive agents, and conjugated estrogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Plasma renin activity, renin substrate and aldosterone during treatment with various oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Vascular reactivity in men and women of reproductive age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900006-4

Biologic effects of various doses of ethinyl estradiol in postmenopausal women

7 January 2021

6

1 reference

https://api.crossref.org/works/10.1016/S0010-7824(03)00006-4

Effect of Oral Contraceptives on Plasma Androgenic Steroids and Their Precursors

1 January 2024

7

1 reference

https://api.crossref.org/works/10.1016/S0010-7824(03)00006-4

1 January 2024

Identifiers

1 reference

3 December 2017

1 reference